PE20091076A1 - Composicion que comprende acidos grasos poliinsaturados y carbon vegetal activado - Google Patents

Composicion que comprende acidos grasos poliinsaturados y carbon vegetal activado

Info

Publication number
PE20091076A1
PE20091076A1 PE2008001803A PE2008001803A PE20091076A1 PE 20091076 A1 PE20091076 A1 PE 20091076A1 PE 2008001803 A PE2008001803 A PE 2008001803A PE 2008001803 A PE2008001803 A PE 2008001803A PE 20091076 A1 PE20091076 A1 PE 20091076A1
Authority
PE
Peru
Prior art keywords
fatty acids
vegetable carbon
composition
activated vegetable
composition including
Prior art date
Application number
PE2008001803A
Other languages
English (en)
Inventor
Catherine Kabaradjian
Original Assignee
Bayer Consumer Care Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Consumer Care Ag filed Critical Bayer Consumer Care Ag
Publication of PE20091076A1 publication Critical patent/PE20091076A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/44—Elemental carbon, e.g. charcoal, carbon black
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Inorganic Chemistry (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

REFERIDA A UNA COMPOSICION ORAL QUE COMPRENDE ACIDOS GRASOS POLIINSATURADOS (PUFA) Y CARBON VEGETAL ACTIVADO, DONDE LOS PUFA SON ACIDOS GRASOS OMEGA-3 Y OMEGA-6, ACIDO ARAQUIDONICO, LINOLEICO, EICOSAPENTENOICO, DOCOSAHEXENOICO, ALFA-LINOLEICO, ACEITE DE PERILLA, ACEITE DE PESCADO O MEZCLAS DE LOS MISMOS Y SE ENCUNTRAN EN UNA CANTIDAD DEL 5% A 70% EN PESO DE LA COMPOSICION. DICHA COMPOSICION SE PRESENTA COMO UN COMPRIMIDO RECUBIERTO O MULTICAPA, DONDE EL CARBON VEGETAL ACTIVADO SE PUEDE ENCONTRAR DISPERSO EN LA MATRIZ O EN EL RECUBRIMIENTO O EN LAS CAPAS EXTERNAS, Y ES UTIL COMO SUPLEMENTO NUTRICIONAL O DIETETICO PARA EQUILIBRAR EL NIVEL LIPIDICO EN SANGRE EN TRANSTORNOSHORMONALES, CEREBROVASCULARES, CARDIOVASCULARES, ENTRE OTROS
PE2008001803A 2007-10-30 2008-10-21 Composicion que comprende acidos grasos poliinsaturados y carbon vegetal activado PE20091076A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07291306 2007-10-30

Publications (1)

Publication Number Publication Date
PE20091076A1 true PE20091076A1 (es) 2009-07-25

Family

ID=40344798

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2008001803A PE20091076A1 (es) 2007-10-30 2008-10-21 Composicion que comprende acidos grasos poliinsaturados y carbon vegetal activado

Country Status (15)

Country Link
US (1) US20100260893A1 (es)
EP (1) EP2214638B1 (es)
AR (1) AR070759A1 (es)
AT (1) ATE541560T1 (es)
AU (1) AU2008317920B2 (es)
BR (1) BRPI0818568A2 (es)
CA (1) CA2703816C (es)
ES (1) ES2379034T3 (es)
MX (1) MX2010003703A (es)
PE (1) PE20091076A1 (es)
PL (1) PL2214638T3 (es)
RU (1) RU2485940C2 (es)
TW (1) TW200942229A (es)
UY (1) UY31410A1 (es)
WO (1) WO2009056247A1 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8586104B2 (en) 2008-04-10 2013-11-19 U.S. Nutraceuticals, LLC Plant derived seed extract rich in essentially fatty acids derived from Salvia hispanica L. seed: composition of matter, manufacturing process and use
US8784904B2 (en) 2008-04-10 2014-07-22 U.S. Nutraceuticals, LLC Plant derived seed extract rich in essential fatty acids derived from perilla seed: composition of matter, manufacturing process and use
US9770047B2 (en) 2008-04-10 2017-09-26 U.S. Nutraceuticals, LLC Perilla seed composition
US9610313B2 (en) 2008-04-10 2017-04-04 U.S. Nutraceuticals Eye health composition and method using plant derived seed extract rich in essential fatty acids derived from perilla seed and carotenoids
WO2012002891A1 (en) * 2010-07-01 2012-01-05 Delante Health As Coated effervescent tablet
US20130115306A1 (en) * 2011-11-09 2013-05-09 Denovo Inc. Toxin decontaminant food product and method of treating disorders of the gastrointestinal tract
RU2524358C2 (ru) * 2012-07-24 2014-07-27 Федеральное государственное бюджетное учреждение "Научно-исследовательский институт питания РАМН" Российской академии медицинских наук (ФГБУ "НИИ питания" РАМН) Функциональный пищевой ингредиент с заданным липидным профилем
EP2994165A4 (en) * 2013-05-10 2017-01-04 Nitromega Corp. Nutritional or dietary supplements containing fatty acids and nitrite
EA025006B1 (ru) * 2013-08-22 2016-11-30 Федеральное государственное бюджетное учреждение "Научно-исследовательский институт питания РАМН" Российской академии медицинских наук (ФГБУ "НИИ питания" РАМН) Функциональный пищевой ингредиент с заданным липидным профилем
CN105935145B (zh) * 2015-12-18 2019-09-20 重庆两江药物研发中心有限公司 一种鱼油植物甾醇复合片剂及其制备方法
CN105919946B (zh) * 2016-05-31 2019-03-12 福格森（武汉）生物科技股份有限公司 一种dha微丸的制备方法
CN110087481A (zh) * 2016-12-15 2019-08-02 帝斯曼知识产权资产管理有限公司 包含硅酸盐和含具有至少20个碳原子的多不饱和脂肪酸(lc-pufa)的微生物细胞和/或植物细胞的共混物制剂
CN111067876B (zh) * 2019-12-04 2022-08-16 宁夏大学 一种α-亚麻酸双层片及其制备方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3702031A1 (de) 1987-01-24 1988-08-04 Basf Ag Verfahren zur herstellung von mikrodispersen fischoelpraeparaten
US5780039A (en) * 1992-04-23 1998-07-14 Novartis Nutrition Ag Orally-ingestible nutrition compositions having improved palatability
JPH0892587A (ja) 1994-09-22 1996-04-09 Baiotsukusu:Kk 魚臭のマスキング法
JP3534881B2 (ja) 1995-02-23 2004-06-07 太陽化学株式会社 乳化組成物
US6630192B2 (en) 1995-04-07 2003-10-07 Brandeis University Increasing the HDL level and the HDL/LDL ratio in human serum by balancing saturated and polyunsaturated dietary fatty acids
JP2001516343A (ja) * 1997-02-21 2001-09-25 アボツト・ラボラトリーズ 壊死性全腸炎の発生を減少させるための方法及び組成物
US6479545B1 (en) * 1999-09-30 2002-11-12 Drugtech Corporation Formulation for menopausal women
ES2246798T3 (es) * 2000-05-18 2006-03-01 Q-Mega Healthcare A/S Complemento dietetico comprendiendo vitaminas, minerales y acidos grasos poliinsaturados.
JP2002204656A (ja) 2001-01-10 2002-07-23 Yakult Honsha Co Ltd 発酵乳飲食品及びその製造方法
DE20105126U1 (de) 2001-03-23 2002-01-31 Bartz, Volker, 35440 Linden Fischöl zur oralen Einnahme
EP1399309A1 (en) * 2001-06-25 2004-03-24 Pharmacia Corporation Compression coated tablets
EP1332759B1 (en) * 2002-02-04 2005-09-28 Kyowa Hakko Kogyo Co., Ltd. Pharmaceutical and nutritional compositions containing a di- or oligosaccharide as insulin secretion promoter
EP1538918A4 (en) 2002-08-14 2006-11-02 Du Pont COATED PARTICLES CONTAINING UNSATURATED FATTY ACID AND COATED LIQUID PHARMACEUTICAL PARTICLES
US20050233074A1 (en) * 2002-08-14 2005-10-20 Dalziel Sean M Solid flowable powder with high liquid loading
EP1670324A1 (en) 2003-09-26 2006-06-21 Nestec S.A. Nutritional composition with unsaturated fatty acids and trace elements
ATE336230T1 (de) * 2004-02-20 2006-09-15 Mattern Udo Orale pharmazeutische zusammensetzung und verfahren zu ihrer herstellung
US20060083786A1 (en) * 2004-07-29 2006-04-20 Glenmark Pharmaceuticals Limited Taste masking pharmaceutical composition containing levocetirizine
WO2007015201A1 (en) * 2005-08-03 2007-02-08 Sasol Technology (Proprietary) Limited Transport and erection of very large vessels
GB0516069D0 (en) * 2005-08-04 2005-09-14 Imp College Innovations Ltd Pharmaceutical and use thereof

Also Published As

Publication number Publication date
UY31410A1 (es) 2009-05-29
WO2009056247A1 (en) 2009-05-07
RU2485940C2 (ru) 2013-06-27
ATE541560T1 (de) 2012-02-15
AU2008317920B2 (en) 2014-03-13
ES2379034T3 (es) 2012-04-20
EP2214638A1 (en) 2010-08-11
MX2010003703A (es) 2010-07-30
RU2010121714A (ru) 2011-12-10
EP2214638B1 (en) 2012-01-18
BRPI0818568A2 (pt) 2015-04-22
AR070759A1 (es) 2010-05-05
CA2703816C (en) 2016-07-19
CA2703816A1 (en) 2009-05-07
PL2214638T3 (pl) 2012-06-29
US20100260893A1 (en) 2010-10-14
AU2008317920A1 (en) 2009-05-07
TW200942229A (en) 2009-10-16

Similar Documents

Publication Publication Date Title
PE20091076A1 (es) Composicion que comprende acidos grasos poliinsaturados y carbon vegetal activado
Timilsena et al. Advances in microencapsulation of polyunsaturated fatty acids (PUFAs)-rich plant oils using complex coacervation: A review
Teoh et al. The implications of substituting dietary fish oil with vegetable oils on the growth performance, fillet fatty acid profile and modulation of the fatty acid elongase, desaturase and oxidation activities of red hybrid tilapia, Oreochromis sp.
Betancor et al. Evaluation of a high-EPA oil from transgenic Camelina sativa in feeds for Atlantic salmon (Salmo salar L.): Effects on tissue fatty acid composition, histology and gene expression
MX349678B (es) Producción de ácidos grasos poliinsaturados de cadena larga en células vegetales.
PE20170431A1 (es) Lipido que comprende acido docosapentaenoico
Guichardant et al. Omega-3 polyunsaturated fatty acids and oxygenated metabolism in atherothrombosis
ATE547005T1 (de) Nährende speiseölzusammensetzungen und verfahren zu ihrer herstellung
MX2011009507A (es) Emulsiones de aceite en agua a base de pescado enriquecidas en omega-3 para nutricion parenteral.
AR072579A1 (es) Aceites no- trans funcionales con relacion omega-6 a omega -3 modulada
MX342216B (es) Composiciones de acidos grasos.
PE20141998A1 (es) Composiciones topicas que comprenden fipronilo y permetrina y sus metodos de uso
MX344271B (es) Productos nutricionales que incluyen un sistema de grasa novedoso que incluye monogliceridos.
AR110343A1 (es) Composiciones nutricionales que contienen butirato y usos de las mismas
AR090072A1 (es) Aceite que comprende acidos grasos poliinsaturados estables a la oxidacion
PE20211003A1 (es) Composiciones de acidos grasos poliinsaturados enriquecidos con dha
MX383445B (es) Composiciones alimenticias para mascotas.
UA111967C2 (uk) Оздоровчий харчовий продукт, що містить етилові естери жирних кислот з лляної олії, і спосіб його одержання
PE20212373A1 (es) Composiciones de acidos grasos poliinsaturados enriquecidos con dha
RU2012128503A (ru) Сбалансированные жировые композиции и их применение в жидких питательных композициях для энтерального питания
PE20212374A1 (es) Composiciones de acidos grasos poliinsaturados enriquecidos con dha
PE20211481A1 (es) Composiciones de acidos grasos poliinsaturados enriquecidos con dha
Tokudome et al. Dietary n-3/long-chain n-3 polyunsaturated fatty acids for prevention of sporadic colorectal tumors: a randomized controlled trial in polypectomized participants
PE20212372A1 (es) Composiciones de acidos grasos poliinsaturados enriquecidos con dha
Mozaffarian Omega-6 fatty acids and cardiovascular disease: An update

Legal Events

Date Code Title Description
FA Abandonment or withdrawal